Mexico should be one of first for vaccine

View previous topic View next topic Go down

Mexico should be one of first for vaccine

Post by dean on Wed Jul 15, 2015 6:59 am

http://mexiconewsdaily.com/news/mexico-should-be-one-of-first-for-vaccine/

Mexico should be one of first for vaccine

Mexico News Daily | Tuesday, July 14, 2015
There’s a vaccine on the way for dengue fever after a signing ceremony in France yesterday, but there’s nothing on the horizon for another mosquito-borne virus that has spread quickly in Mexico.


This country is on track to be one of the first countries in the world to implement dengue vaccinations following the signing of an agreement between the Health Secretariat and drug maker Sanofi Pasteur.

Clinical trials of a drug designed to combat what has been described as the world’s fastest-growing tropical disease wrapped up last September, when it was announced that Mexico would probably be one of the first recipients.



A Sanofi Pasteur official said in June that the company was ready to distribute the drug, it having proved effective against the four types of dengue. Mexico was one of countries to participate in the trials, which began in 2004 and took 10 years to complete.

- See more at: http://mexiconewsdaily.com/news/mexico-should-be-one-of-first-for-vaccine/#sthash.L6fhA55N.dpuf

dean

Posts : 3754
Join date : 2008-01-01

View user profile

Back to top Go down

Re: Mexico should be one of first for vaccine

Post by dean on Fri Dec 11, 2015 6:42 am



Dengue vaccine in Mexico early next year
It will be the first country in the world to have it



http://mexiconewsdaily.com/news/dengue-vaccine-in-mexico-early-next-year/

lpg wrote:Mexico will be the first country in the world to have a vaccine available for dengue fever when it begins shipping early next year following approval today by Mexican authorities.


But the new vaccine, developed by the French pharmaceutical firm Sanofi, has produced the best results among people with previous exposure to the virus.

Guillaume Leroy, leader of the dengue team at Sanofi Pasteur, the company’s vaccines division, said the vaccine acted best as an immunity booster for such people.

Dengue fever is a mosquito-borne disease seen by the World Health Organization as a threat to about half the world’s population. Some 400 million people are believed to be infected annually.

Called Dengvaxia, the vaccine has only been approved in Mexico for patients aged nine to 45 who live in areas where the disease is endemic, barring its use for younger children — considered to be more at risk — and tourists.

Leroy added that additional data will be needed before considering whether the vaccine may be of use to travelers.

“Mexico is one of the countries where we started our clinical trials, which has been associated with the program from the very beginning and whose regulatory authority is certified by the World Health Organization,” said Sanofi Pasteur executive vice-president of vaccines, Olivier Charmeil.

ADVERTISEMENT

Mexican regulators cleared the use of the vaccine based on the results of a clinical testing program that included over 40,000 people of different ages from 15 countries.

During the trials, the vaccine reduced the risk of hospitalization by 80% and lowered the possibility of developing the most severe, hemorrhagic form of the disease by 93%.

Deliveries to Mexico from a plant near Lyon, France, will start early next year, said Charmeil and Leroy.

Charmeil said the drug’s pricing would be determined with the Mexican government over the next few weeks. He told the Wall Street Journal that the price would reflect the “value” of the vaccine in terms of the savings that it could bring about elsewhere. He said the total annual cost of treating dengue was around $9 billion globally, and that prevention strategies such as mosquito nets cost a further $6 billion to $9 billion.

Dengvaxia is shaping up to be a “blockbuster” product for the company, said Charmeil, who added that the vaccine is the “innovation of the decade” and is expected to generate over US $1 billion per year in sales.

Other drugmakers including Japan’s Takeda and the United States’ Merck are also working on dengue vaccines but are believed to be several years behind.

In Mexico, 7,136 cases of dengue were reported between January 1 and July 28 5,728 of which were classic and 1,408 hemorrhagic, with 11 deaths.

- See more at: http://mexiconewsdaily.com/news/dengue-vaccine-in-mexico-early-next-year/#sthash.V2w91Atx.dpuf

dean

Posts : 3754
Join date : 2008-01-01

View user profile

Back to top Go down

View previous topic View next topic Back to top

- Similar topics

 
Permissions in this forum:
You cannot reply to topics in this forum